Larcaviximab
Modify Date: 2025-09-12 19:52:26
Larcaviximab structure
|
Common Name | Larcaviximab | ||
|---|---|---|---|---|
| CAS Number | 1792982-56-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LarcaviximabLarcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1]. |
| Name | Larcaviximab |
|---|
| Description | Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |